English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 135 | Tables: 250 | Pharma & Healthcare
Porcine circovirus type 2 mainly causes multisystem failure disease characterized by generalized lymphadenopathy in pigs, clinically manifested as multisystem failure syndrome, porcine dermatitis and nephritic syndrome, and porcine respiratory disease syndrome in weaned piglets , sow reproductive disorders, necrotizing lymphadenitis, granulomatous enteritis and exudative epidermatitis, etc. The vaccine can significantly improve the production performance of pig farms, significantly increase the growth rate, survival rate and feed utilization rate of pigs at all stages, and significantly reduce the incidence of disease and death rate.
The global market for Porcine Circovirus Type 2 (PCV2) Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Porcine Circovirus Type 2 (PCV2) Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Porcine Circovirus Type 2 (PCV2) Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Porcine Circovirus Type 2 (PCV2) Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Porcine Circovirus Type 2 (PCV2) Vaccine include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Porcine Circovirus Type 2 (PCV2) Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Porcine Circovirus Type 2 (PCV2) Vaccine by region & country, by Type, and by Application.
The Porcine Circovirus Type 2 (PCV2) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Circovirus Type 2 (PCV2) Vaccine.
Market Segmentation
By Company
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry
Segment by Type:
WH Type
LG Type
SH Type
SD Type
ZJ C Type
Others
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Porcine Circovirus Type 2 (PCV2) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Porcine Circovirus Type 2 (PCV2) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Porcine Circovirus Type 2 (PCV2) Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Porcine Circovirus Type 2 (PCV2) Vaccine Product Introduction
1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size Forecast
1.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030)
1.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume (2019-2030)
1.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Price (2019-2030)
1.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends & Drivers
1.3.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industry Trends
1.3.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers & Opportunity
1.3.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
1.3.4 Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Players Revenue Ranking (2023)
2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Company (2019-2024)
2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Players Sales Volume Ranking (2023)
2.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Porcine Circovirus Type 2 (PCV2) Vaccine
2.9 Porcine Circovirus Type 2 (PCV2) Vaccine Market Competitive Analysis
2.9.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Porcine Circovirus Type 2 (PCV2) Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Type 2 (PCV2) Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 WH Type
3.1.2 LG Type
3.1.3 SH Type
3.1.4 SD Type
3.1.5 ZJ C Type
3.1.6 Others
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type
3.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type
3.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application
4.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application
4.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region
5.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region
5.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
5.4.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
5.5.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
5.7.2 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value
6.2.1 Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.3.2 United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.4.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.5.2 China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.6.2 Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.7.2 South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019-2030
6.9.2 India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis Animal Health
7.1.1 Zoetis Animal Health Company Information
7.1.2 Zoetis Animal Health Introduction and Business Overview
7.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.1.5 Zoetis Animal Health Recent Development
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Company Information
7.2.2 Boehringer-Ingelheim Introduction and Business Overview
7.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.2.5 Boehringer-Ingelheim Recent Development
7.3 Merck Animal Health
7.3.1 Merck Animal Health Company Information
7.3.2 Merck Animal Health Introduction and Business Overview
7.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.3.5 Merck Animal Health Recent Development
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Information
7.4.2 Ceva Santé Animale Introduction and Business Overview
7.4.3 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.4.5 Ceva Santé Animale Recent Development
7.5 MSD Animal Health
7.5.1 MSD Animal Health Company Information
7.5.2 MSD Animal Health Introduction and Business Overview
7.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.5.5 MSD Animal Health Recent Development
7.6 SPAH
7.6.1 SPAH Company Information
7.6.2 SPAH Introduction and Business Overview
7.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.6.5 SPAH Recent Development
7.7 Nanjing Tianbang Biological Technology
7.7.1 Nanjing Tianbang Biological Technology Company Information
7.7.2 Nanjing Tianbang Biological Technology Introduction and Business Overview
7.7.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.7.5 Nanjing Tianbang Biological Technology Recent Development
7.8 Sichuan Huapai Bio-pharmaceutical
7.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
7.8.2 Sichuan Huapai Bio-pharmaceutical Introduction and Business Overview
7.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.8.5 Sichuan Huapai Bio-pharmaceutical Recent Development
7.9 Guangdong Winsun Bio Pharmaceutical
7.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
7.9.2 Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
7.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.9.5 Guangdong Winsun Bio Pharmaceutical Recent Development
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Company Information
7.10.2 Wuhan Keqian Biology Introduction and Business Overview
7.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.10.5 Wuhan Keqian Biology Recent Development
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Company Information
7.11.2 Shanghai Hile Bio-Technology Introduction and Business Overview
7.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.11.5 Shanghai Hile Bio-Technology Recent Development
7.12 Harbin Pharmaceutical Group Bio-Vaccine
7.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
7.12.2 Harbin Pharmaceutical Group Bio-Vaccine Introduction and Business Overview
7.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Development
7.13 Ringpu
7.13.1 Ringpu Company Information
7.13.2 Ringpu Introduction and Business Overview
7.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.13.5 Ringpu Recent Development
7.14 Shandong Huahong Bioengineering
7.14.1 Shandong Huahong Bioengineering Company Information
7.14.2 Shandong Huahong Bioengineering Introduction and Business Overview
7.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.14.5 Shandong Huahong Bioengineering Recent Development
7.15 Weike Biotechnology
7.15.1 Weike Biotechnology Company Information
7.15.2 Weike Biotechnology Introduction and Business Overview
7.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.15.5 Weike Biotechnology Recent Development
7.16 Nanjing Tianbang Biological Technology
7.16.1 Nanjing Tianbang Biological Technology Company Information
7.16.2 Nanjing Tianbang Biological Technology Introduction and Business Overview
7.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.16.5 Nanjing Tianbang Biological Technology Recent Development
7.17 China Animal Husbandry Industry
7.17.1 China Animal Husbandry Industry Company Information
7.17.2 China Animal Husbandry Industry Introduction and Business Overview
7.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
7.17.5 China Animal Husbandry Industry Recent Development
8 Industry Chain Analysis
8.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
8.2 Porcine Circovirus Type 2 (PCV2) Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Porcine Circovirus Type 2 (PCV2) Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Porcine Circovirus Type 2 (PCV2) Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends
Table 2. Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers & Opportunity
Table 3. Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
Table 4. Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
Table 5. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Company (2019-2024) & (K Doses)
Table 8. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Porcine Circovirus Type 2 (PCV2) Vaccine Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Porcine Circovirus Type 2 (PCV2) Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Porcine Circovirus Type 2 (PCV2) Vaccine
Table 13. Global Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Type 2 (PCV2) Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)
Table 22. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)
Table 34. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 35. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 36. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030
Table 46. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2019-2024) & (K Doses)
Table 47. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2025-2030) & (K Doses)
Table 48. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, (2019-2024) & (K Doses)
Table 56. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume, (2025-2030) & (K Doses)
Table 57. Zoetis Animal Health Company Information
Table 58. Zoetis Animal Health Introduction and Business Overview
Table 59. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 61. Zoetis Animal Health Recent Development
Table 62. Boehringer-Ingelheim Company Information
Table 63. Boehringer-Ingelheim Introduction and Business Overview
Table 64. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 66. Boehringer-Ingelheim Recent Development
Table 67. Merck Animal Health Company Information
Table 68. Merck Animal Health Introduction and Business Overview
Table 69. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 71. Merck Animal Health Recent Development
Table 72. Ceva Santé Animale Company Information
Table 73. Ceva Santé Animale Introduction and Business Overview
Table 74. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 76. Ceva Santé Animale Recent Development
Table 77. MSD Animal Health Company Information
Table 78. MSD Animal Health Introduction and Business Overview
Table 79. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 81. MSD Animal Health Recent Development
Table 82. SPAH Company Information
Table 83. SPAH Introduction and Business Overview
Table 84. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 86. SPAH Recent Development
Table 87. Nanjing Tianbang Biological Technology Company Information
Table 88. Nanjing Tianbang Biological Technology Introduction and Business Overview
Table 89. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 91. Nanjing Tianbang Biological Technology Recent Development
Table 92. Sichuan Huapai Bio-pharmaceutical Company Information
Table 93. Sichuan Huapai Bio-pharmaceutical Introduction and Business Overview
Table 94. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 96. Sichuan Huapai Bio-pharmaceutical Recent Development
Table 97. Guangdong Winsun Bio Pharmaceutical Company Information
Table 98. Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
Table 99. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 101. Guangdong Winsun Bio Pharmaceutical Recent Development
Table 102. Wuhan Keqian Biology Company Information
Table 103. Wuhan Keqian Biology Introduction and Business Overview
Table 104. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 106. Wuhan Keqian Biology Recent Development
Table 107. Shanghai Hile Bio-Technology Company Information
Table 108. Shanghai Hile Bio-Technology Introduction and Business Overview
Table 109. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 111. Shanghai Hile Bio-Technology Recent Development
Table 112. Harbin Pharmaceutical Group Bio-Vaccine Company Information
Table 113. Harbin Pharmaceutical Group Bio-Vaccine Introduction and Business Overview
Table 114. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 116. Harbin Pharmaceutical Group Bio-Vaccine Recent Development
Table 117. Ringpu Company Information
Table 118. Ringpu Introduction and Business Overview
Table 119. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 121. Ringpu Recent Development
Table 122. Shandong Huahong Bioengineering Company Information
Table 123. Shandong Huahong Bioengineering Introduction and Business Overview
Table 124. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 126. Shandong Huahong Bioengineering Recent Development
Table 127. Weike Biotechnology Company Information
Table 128. Weike Biotechnology Introduction and Business Overview
Table 129. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 130. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 131. Weike Biotechnology Recent Development
Table 132. Nanjing Tianbang Biological Technology Company Information
Table 133. Nanjing Tianbang Biological Technology Introduction and Business Overview
Table 134. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 135. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 136. Nanjing Tianbang Biological Technology Recent Development
Table 137. China Animal Husbandry Industry Company Information
Table 138. China Animal Husbandry Industry Introduction and Business Overview
Table 139. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 140. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Offerings
Table 141. China Animal Husbandry Industry Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Porcine Circovirus Type 2 (PCV2) Vaccine Downstream Customers
Table 145. Porcine Circovirus Type 2 (PCV2) Vaccine Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Circovirus Type 2 (PCV2) Vaccine Product Picture
Figure 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume (2019-2030) & (K Doses)
Figure 5. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Price (2019-2030) & (US$/Dose)
Figure 6. Porcine Circovirus Type 2 (PCV2) Vaccine Report Years Considered
Figure 7. Global Porcine Circovirus Type 2 (PCV2) Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Porcine Circovirus Type 2 (PCV2) Vaccine Players Sales Volume Ranking (2023) & (K Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Circovirus Type 2 (PCV2) Vaccine Revenue in 2023
Figure 10. Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. WH Type Picture
Figure 12. LG Type Picture
Figure 13. SH Type Picture
Figure 14. SD Type Picture
Figure 15. ZJ C Type Picture
Figure 16. Others Picture
Figure 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Type (2019-2030) & (US$/Dose)
Figure 22. Product Picture of Piglets
Figure 23. Product Picture of Adults Pigs
Figure 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 27. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Application (2019-2030) & (US$/Dose)
Figure 29. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Porcine Circovirus Type 2 (PCV2) Vaccine Sales Volume (%), (2019-2030)
Figure 41. United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 47. China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 49. China Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 59. India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 61. India Porcine Circovirus Type 2 (PCV2) Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 62. Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
Figure 63. Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
